Raleigh Capital Management Inc. Horizon Therapeutics Public LTD CO Transaction History

Raleigh Capital Management Inc.

  • $255 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$58.92 - $84.67 $149,774 - $215,231
-2,542 Reduced 98.3%
44 $3,000
Q2 2022

Aug 30, 2022
SELL
$79.4 - $116.36 $32,077 - $47,009
-404 Reduced 13.51%
2,586 $206,000
Q1 2022

May 12, 2022
BUY
$86.42 - $109.81 $62,222 - $79,063
720 Added 31.72%
2,990 $314,000
Q4 2021

Feb 16, 2022
BUY
$98.56 - $119.91 $223,731 - $272,195
2,270 New
2,270 $244,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email